Monepantel Production Cost Reports

The report provides a detailed analysis essential for establishing a monepantel production plant. It encompasses all critical aspects necessary for monepantel production, including the cost of monepantel production, monepantel plant cost, monepantel production costs, and the overall monepantel production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a monepantel production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Monepantel is a synthetic anthelmintic compound that is mainly used in veterinary medicine. It is primarily utilised for the treatment and control of gastrointestinal parasitic worms in livestock, especially sheep and goats. It works by targeting specific receptors in parasites, which leads to their paralysis and death, while remaining safe for the treated animals when used at recommended doses. It is widely utilised in managing infections caused by nematodes, including strains that have developed resistance to older deworming drugs. It is commonly formulated as oral drenches or suspensions to ensure easy administration in farm animals. It also finds its main application in animal husbandry, where it helps improve animal health, weight gain, and overall productivity by reducing parasite burden. Moreover, it is often included in parasite management programs to control worms that have developed resistance to older treatments.

The demand for monepantel is primarily driven by its application as a veterinary anthelmintic medicine for supporting sustainable livestock farming by managing parasitic infections, which promotes its market growth. Its application as an antiparasitic agent for the treatment and control of gastrointestinal worms in animals such as sheep and goats significantly boosts its demand in the veterinary industry. Its utilisation as a part of parasite control programs to improve animal health, weight gain, and overall productivity further supports its demand in animal husbandry. Its usage as an oral drug in managing infections for large-scale use on farms and in commercial livestock operations also contributes to its demand in the livestock or animal healthcare industry. Moreover, the growing focus on improving animal productivity, meat quality, and farm profitability continues to fuel its use in the veterinary pharmaceutical industry. Furthermore, production capabilities, supplier consistency, quality control measures, and efficient distribution networks significantly impact industrial monepantel procurement across global livestock markets. Factors such as the cost and availability of active pharmaceutical ingredients, regulatory approvals for veterinary medicines, and compliance with residue and safety standards also influence its procurement processes.

Raw Material for Monepantel Production

According to the monepantel production plant project report, the major raw materials for monepantel production include 3-(2-oxo-propoxy)-4-(trifluoromethyl)benzonitrile and ammonia.

Production Process of Monepantel

The extensive monepantel production cost report consists of the following industrial production process:

1. Production via Chemical Synthesis: The production process of monepantel begins with 3-(2-oxo-propoxy)-4-(trifluoromethyl)benzonitrile, which is reacted with ammonia in methanol to form an intermediate amide compound. Then, this intermediate undergoes a tert-butyl nitration step in the presence of palladium acetate as a catalyst, which allows the required side chain to be introduced into the molecule. After completion of the reaction, the mixture is processed to separate and dry the product, which gives a crude hydrochloride form. This crude material is purified through recrystallisation using water and isopropanol to improve its quality. In the final step, the compound is treated with ammonia water under alkaline conditions to obtain the active (S)-enantiomer of monepantel as the desired product.

Monepantel is a novel anthelmintic compound belonging to the aminoacetonitrile derivative class, and it acts as a potent antiparasitic agent against gastrointestinal nematodes. It appears as a white powdery solid that is generally formulated for pharmaceutical applications. The molecular formula of the compound is C20H13F6N3O2S, and its molecular mass is 473.39 g/mol. It has a density of 1.46 g/cm3. The compound exhibits stereoisomerism due to the presence of a chiral centre in its molecular structure, with only the (S)-enantiomer demonstrating significant biological activity. The compound decomposes on heating and does not exhibit a defined atmospheric boiling point. It is produced through multi-step organic synthesis and is supplied as a non-aqueous solution for oral administration in veterinary medicine. It is a pharmaceutical compound that requires appropriate handling and storage conditions to maintain its stability and efficacy. It should be used strictly under veterinary supervision for its approved indications in livestock.